364 related articles for article (PubMed ID: 26677843)
1. Clinical parameters related to metamorphopsia outcome in patients with resolved central serous chorioretinopathy using M-CHARTS: retrospective cohort study.
Bae S; Jin K; Kim H; Bae SH
BMC Ophthalmol; 2015 Dec; 15():180. PubMed ID: 26677843
[TBL] [Abstract][Full Text] [Related]
2. Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy.
Gawęcki M; Jaszczuk-Maciejewska A; Jurska-Jaśko A; Kneba M; Grzybowski A
BMC Ophthalmol; 2019 Jul; 19(1):160. PubMed ID: 31345183
[TBL] [Abstract][Full Text] [Related]
3. Detection of morphologic alterations by spectral-domain optical coherence tomography before and after half-dose verteporfin photodynamic therapy in chronic central serous chorioretinopathy.
Shinojima A; Kawamura A; Mori R; Fujita K; Yuzawa M
Retina; 2011 Oct; 31(9):1912-20. PubMed ID: 21952105
[TBL] [Abstract][Full Text] [Related]
4. Quantification of metamorphopsia in chronic central serous chorioretinopathy after half-dose verteporfin photodynamic therapy.
Fujita K; Imamura Y; Shinoda K; Matsumoto CS; Mizutani Y; Mizota A; Yuzawa M
Retina; 2014 May; 34(5):964-70. PubMed ID: 24406387
[TBL] [Abstract][Full Text] [Related]
5. Subretinal hyperreflective material in central serous chorioretinopathy.
Sahoo NK; Govindhari V; Bedi R; Goud A; Singh R; Wu L; Chhablani J
Indian J Ophthalmol; 2020 Jan; 68(1):126-129. PubMed ID: 31856489
[TBL] [Abstract][Full Text] [Related]
6. PREVALENCE AND MORPHOLOGIC BIOMARKERS OF METAMORPHOPSIA IN EYES WITH "RESOLVED" CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.
Borrelli E; Barresi C; Battista M; Berni A; Ricardi F; Cascavilla ML; Reibaldi M; Bandello F
Retina; 2023 Sep; 43(9):1563-1572. PubMed ID: 37229754
[TBL] [Abstract][Full Text] [Related]
7. Association of Choroidal Neovascularization and Central Serous Chorioretinopathy With Optical Coherence Tomography Angiography.
Bonini Filho MA; de Carlo TE; Ferrara D; Adhi M; Baumal CR; Witkin AJ; Reichel E; Duker JS; Waheed NK
JAMA Ophthalmol; 2015 Aug; 133(8):899-906. PubMed ID: 25996386
[TBL] [Abstract][Full Text] [Related]
8. A Multicenter Study on the Long-term Outcomes of Half-dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy.
Lai FH; Ng DS; Bakthavatsalam M; Chan VC; Young AL; Luk FO; Tsang CW; Brelén ME
Am J Ophthalmol; 2016 Oct; 170():91-99. PubMed ID: 27519561
[TBL] [Abstract][Full Text] [Related]
9. Acute central serous chorioretinopathy: a correlation study between fundus autofluorescence and spectral-domain OCT.
Iacono P; Battaglia PM; Papayannis A; La Spina C; Varano M; Bandello F
Graefes Arch Clin Exp Ophthalmol; 2015 Nov; 253(11):1889-97. PubMed ID: 25563727
[TBL] [Abstract][Full Text] [Related]
10. Correlation of spectral domain optical coherence tomography findings and visual acuity in central serous chorioretinopathy.
Yalcinbayir O; Gelisken O; Akova-Budak B; Ozkaya G; Gorkem Cevik S; Yucel AA
Retina; 2014 Apr; 34(4):705-12. PubMed ID: 24100708
[TBL] [Abstract][Full Text] [Related]
11. Correlation between outer retinal layer thickness and cone density in patients with resolved central serous chorioretinopathy.
Nakamura T; Ueda-Consolvo T; Oiwake T; Hayashi A
Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2347-2354. PubMed ID: 27255458
[TBL] [Abstract][Full Text] [Related]
12. BASELINE SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHIC HYPERREFLECTIVE FOCI AS A PREDICTOR OF VISUAL OUTCOME AND RECURRENCE FOR CENTRAL SEROUS CHORIORETINOPATHY.
Lee H; Lee J; Chung H; Kim HC
Retina; 2016 Jul; 36(7):1372-80. PubMed ID: 26702841
[TBL] [Abstract][Full Text] [Related]
13. Factors influencing the visual acuity of chronic central serous chorioretinopathy.
Kim YY; Flaxel CJ
Korean J Ophthalmol; 2011 Apr; 25(2):90-7. PubMed ID: 21461220
[TBL] [Abstract][Full Text] [Related]
14. High-resolution imaging of resolved central serous chorioretinopathy using adaptive optics scanning laser ophthalmoscopy.
Ooto S; Hangai M; Sakamoto A; Tsujikawa A; Yamashiro K; Ojima Y; Yamada Y; Mukai H; Oshima S; Inoue T; Yoshimura N
Ophthalmology; 2010 Sep; 117(9):1800-9, 1809.e1-2. PubMed ID: 20673590
[TBL] [Abstract][Full Text] [Related]
15. Preferential hyperacuity perimeter and prognostic factors for metamorphopsia after idiopathic epiretinal membrane surgery.
Bae SH; Kim D; Park TK; Han JR; Kim H; Nam W
Am J Ophthalmol; 2013 Jan; 155(1):109-117.e3. PubMed ID: 23022166
[TBL] [Abstract][Full Text] [Related]
16. Multimodal imaging findings in a case of severe Central Serous Chorioretinopathy in an uncomplicated pregnancy.
Maggio E; Polito A; Freno MC; Pertile G
BMC Ophthalmol; 2015 Dec; 15():183. PubMed ID: 26695180
[TBL] [Abstract][Full Text] [Related]
17. Central serous chorioretinopathy in patients receiving exogenous testosterone therapy.
Nudleman E; Witmer MT; Kiss S; Williams GA; Wolfe JD
Retina; 2014 Oct; 34(10):2128-32. PubMed ID: 24946102
[TBL] [Abstract][Full Text] [Related]
18. High-resolution imaging of the photoreceptor layer in epiretinal membrane using adaptive optics scanning laser ophthalmoscopy.
Ooto S; Hangai M; Takayama K; Sakamoto A; Tsujikawa A; Oshima S; Inoue T; Yoshimura N
Ophthalmology; 2011 May; 118(5):873-81. PubMed ID: 21074858
[TBL] [Abstract][Full Text] [Related]
19. Macular ganglion cell complex thickness in acute and chronic central serous chorioretinopathy.
Demirok G; Kocamaz F; Topalak Y; Altay Y; Sengun A
Int Ophthalmol; 2017 Apr; 37(2):409-416. PubMed ID: 27324370
[TBL] [Abstract][Full Text] [Related]
20. Retro-mode Imaging for retinal pigment epithelium alterations in central serous chorioretinopathy.
Shin YU; Lee BR
Am J Ophthalmol; 2012 Jul; 154(1):155-163.e4. PubMed ID: 22503695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
